Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Dysgeusia
ADR ID BADD_A01361
ADR Hierarchy
17      Nervous system disorders
17.02      Neurological disorders NEC
17.02.07      Sensory abnormalities NEC
17.02.07.003      Dysgeusia
07      Gastrointestinal disorders
07.14      Tongue conditions
07.14.03      Taste disorders
07.14.03.001      Dysgeusia
Description A disorder characterized by abnormal sensual experience with the taste of foodstuffs; it can be related to a decrease in the sense of smell. [CTCAE] A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality. [MeSH]
MedDRA Code 10013911
MeSH ID D004408
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
After taste | Bad taste | Dysgensia | Dysgeusia | Parageusia | Taste bitter | Taste bitter-salty | Taste garlic | Taste metallic | Taste peculiar | Taste perversion | Taste perversion of | Taste salty | Taste sour | Taste sweet | Bilious taste | Chalky taste | Phantom taste perception | Cacogeusia | Taste chemical | Taste astringent | Taste pungent | Dysgeusias | Taste, Distorted | Distorted Taste | Taste, Altered | Altered Taste | Parageusias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02395Zolpidem tartrate--
BADD_D02396Zonisamide--
BADD_D02397Zopiclone--
BADD_D02412Octreotide--
BADD_D02416Ropivacaine0.001000%
BADD_D02428Loperamide--
BADD_D02439Levodopa0.000807%
BADD_D02440Lisdexamfetamine0.002044%
BADD_D02443Tiotropium0.000494%
BADD_D02445Solifenacin0.000972%
BADD_D02463Pitavastatin0.003915%
BADD_D02464Fingolimod--
BADD_D02465Aclidinium0.005165%
BADD_D02467Naloxegol0.002239%
BADD_D02470Nintedanib0.001321%
BADD_D02472Sonidegib0.000828%
BADD_D02480Alectinib0.000492%
BADD_D02488Esketamine0.002748%
BADD_D02489Neratinib0.002015%
BADD_D02490Apalutamide0.006006%
BADD_D02498Abemaciclib0.001522%
BADD_D02506Erdafitinib0.000246%
BADD_D02510Rucaparib0.034508%
BADD_D02512Secnidazole0.000963%
BADD_D02514Etelcalcetide0.013679%
BADD_D02515Pexidartinib0.002071%
BADD_D02517Enasidenib0.001332%
BADD_D02520Baloxavir marboxil0.000423%
BADD_D02524Ivosidenib0.000381%
BADD_D02531Avapritinib0.000112%
The 27th Page    First    Pre   27 28    Next   Last    Total 28 Pages